Counterfeit Condoms from China Seized in Europe – OLAF Removes 200,000 Units from Circulation

Brussels, July 7, 2026

The European Anti-Fraud Office (OLAF) has seized around 200,000 counterfeit condoms that had been smuggled from China into the EU and sold in several European countries under the name of a well-known brand.

According to the authorities, the counterfeit condoms were marketed under the name and logo of a well-known brand. OLAF estimates the market value of the seized goods at more than 200,000 euros.

As the agency further announced, initial tips from national authorities triggered the investigation. Subsequently, OLAF traced the smuggling route of the fake condoms and, together with customs authorities in Romania, Serbia and Spain, examined the seized products. The Brussels-based agency did not disclose the exact brand name upon request.

Background of the Investigation

Laboratory tests confirmed that the goods do not meet EU quality requirements for medical products. Specifically, this concerns tests for durability, stability and contamination. The counterfeits were falsely declared as toys in the shipping documents in order to disguise their import.

OLAF Director Petr Klement said the counterfeit condoms originated from the same source in China. OLAF was able to identify the exporters of the shipments in cooperation with Chinese authorities. This now makes it possible to further pursue those responsible in the supply chain.

Klement also warned of the health risks for consumers. Such products enable the spread of sexually transmitted diseases. In addition, untested condoms can fail as contraceptives, which can result in unwanted pregnancies.

Risks for Consumers

In a notice from the European Anti-Fraud Office (OLAF), it states that the agency has published the results of the investigation in an official communication. OLAF works closely with the European Anti-Fraud Office, EU customs and national consumer protection authorities to stop the spread of counterfeit medical products.

The current operation is part of a growing number of cases in which counterfeit or substandard medical products enter the European single market. Observers see this as a sign that criminals are increasingly exploiting complex supply chains to bring illegal goods to consumers.

Cooperation Between Authorities

According to OLAF, consumers can contact national medicines regulatory authorities or consumer protection agencies, among others, if they are unsure whether a product is genuine. OLAF itself is an investigative body and does not accept direct consumer inquiries.

Overall, according to OLAF, the investigations show that authorities at both the European and national level are able to detect cross-border counterfeits and remove them from circulation. The investigations against the identified exporters are ongoing.

By publishing the case, OLAF also aims to send a signal to the trade sector. Retailers and platforms must carefully examine their supply chains to prevent counterfeit contraceptives from entering the legal market.